Loading...

Bio-Rad Laboratories, Inc.

BIO-BNYSE
Healthcare
Medical - Devices
$247.05
$0.00(0.00%)

Bio-Rad Laboratories, Inc. (BIO-B) Stock Overview

Explore Bio-Rad Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 69.6/100

Key Financials

Market Cap6.8B
P/E Ratio24.17
EPS (TTM)$-76.53
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Week$258.20
1 Month$258.97
3 Months$340.39
1 Year Target$268.65

BIO-B Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bio-Rad Laboratories, Inc. (BIO-B) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $268.65.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 24.17 and a market capitalization of 6.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;